Insider filing · SYRE
Cameron Turtle
Chief Executive Officer
profile →
Spyre Therapeutics, Inc.
SYRE · Healthcare · 29 filings in 24 months
ticker →
Cameron Turtle sold $1.4M of Spyre Therapeutics (SYRE)
Executed Aug 3, disclosed Aug 6, 2 days later.
Value, as filed
$1.4M
14,184 sh across 3 lots
Executed
Aug 3
the trade date, as filed
Disclosed
Aug 6
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CTCameron Turtle (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $1.4M of SYRE (14,184 sh across 3 lots, as filed), executed Aug 3.
The name
SYREHealthcare · Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Cameron Turtle in SYRE
SYRESALE
Spyre Therapeutics, Inc.
$1.3M14,600 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:33 PM ET SYRESALE Spyre Therapeutics, Inc. $1.3M
14,410 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 9:32 PM ET SYRESALE Spyre Therapeutics, Inc. $1.1M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $976K
13,700 sh across 4 lots
Exec May 1
Filed May 1 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $740K
15,000 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $633K
15,000 sh across 2 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $462K
14,043 sh × $32.87
Exec Feb 2
Filed Feb 4 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $387K
12,709 sh × $30.47
Exec Jan 2
Filed Jan 6 · 5:30 PM ET